Home/Filings/4/0001209191-10-011288
4//SEC Filing

PITLER DAVID 4

Accession 0001209191-10-011288

CIK 0000822418other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 12:51 PM ET

Size

17.9 KB

Accession

0001209191-10-011288

Insider Transaction Report

Form 4
Period: 2010-02-19
PITLER DAVID
Sr. V.P., Operations
Transactions
  • Exercise/Conversion

    Option to purchase Common Stock

    2010-02-1914,500193,500 total
    Exercise: $1.28From: 2000-03-06Exp: 2010-03-06Common Stock (14,500 underlying)
  • Exercise/Conversion

    Option to purchase Common Stock

    2010-02-2226,000165,000 total
    Exercise: $1.28From: 2000-03-06Exp: 2010-03-06Common Stock (26,000 underlying)
  • Sale

    Common stock

    2010-02-19$4.28/sh14,500$62,06010,000 total
  • Sale

    Common stock

    2010-02-22$4.21/sh2,500$10,52510,000 total
  • Exercise/Conversion

    Common stock

    2010-02-22$1.28/sh+26,000$33,28036,000 total
  • Exercise/Conversion

    Option to purchase Common stock

    2010-02-222,500191,000 total
    Exercise: $1.28From: 2000-03-06Exp: 2010-03-06Common Stock (2,500 underlying)
Footnotes (3)
  • [F1]Such amount represents the average closing price of the common stock sold. The breakdown is as follows: 14,500 shares at $4.28.
  • [F2]Such amount represents the average closing price of the common stock sold. The breakdown is as follows: 2,500 shares at $4.21.
  • [F3]Includes multiple option grants with different exercise prices and vesting dates.

Issuer

BIOCLINICA INC

CIK 0000822418

Entity typeother

Related Parties

1
  • filerCIK 0001234178

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 12:51 PM ET
Size
17.9 KB